serine has been researched along with Acute Edematous Pancreatitis in 7 studies
Serine: A non-essential amino acid occurring in natural form as the L-isomer. It is synthesized from GLYCINE or THREONINE. It is involved in the biosynthesis of PURINES; PYRIMIDINES; and other amino acids.
serine : An alpha-amino acid that is alanine substituted at position 3 by a hydroxy group.
| Excerpt | Relevance | Reference |
|---|---|---|
| "We analysed whether administration of an L-serine-enriched diet to mouse models of diabetes, an established method for decreasing the synthesis of 1-deoxysphingolipids in vivo, reduced the severity of acute pancreatitis." | 7.96 | Serine administration as a novel prophylactic approach to reduce the severity of acute pancreatitis during diabetes in mice. ( Chen, R; Graf, R; Henstridge, DC; Hills, AP; Hornemann, T; Malagola, E; Reding, T; Schraner, EM; Sonda, S; Štefanić, S; Zuellig, R, 2020) |
| " Nafamostat mesylate (nafamostat) is a drug licensed in Japan and Korea for indications including acute pancreatitis and disseminated intravascular coagulation." | 5.22 | Nafamostat Mesylate for Treatment of COVID-19 in Hospitalised Patients: A Structured, Narrative Review. ( Bowen, AC; Denholm, JT; Dore, GJ; Hernández-Mitre, MP; Hills, TE; Lewin, SR; McQuilten, Z; Morpeth, SC; Paterson, DL; Roberts, JA; Tong, SYC; Venkatesh, B, 2022) |
| "We analysed whether administration of an L-serine-enriched diet to mouse models of diabetes, an established method for decreasing the synthesis of 1-deoxysphingolipids in vivo, reduced the severity of acute pancreatitis." | 3.96 | Serine administration as a novel prophylactic approach to reduce the severity of acute pancreatitis during diabetes in mice. ( Chen, R; Graf, R; Henstridge, DC; Hills, AP; Hornemann, T; Malagola, E; Reding, T; Schraner, EM; Sonda, S; Štefanić, S; Zuellig, R, 2020) |
| "Severe hypertriglyceridemia is a major risk for acute pancreatitis." | 1.31 | Severe hypertriglyceridemia with plasma inhibitory factor(s) on lipoprotein lipase activity in a patient with a common Ser(447)-Ter LPL mutation. ( Bujo, H; Kanoh, T; Kobayashi, J; Koshikawa, H; Saito, Y; Sasaki, Y; Taira, K; Takahashi, K; Zhu, Y, 2001) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (28.57) | 18.7374 |
| 1990's | 1 (14.29) | 18.2507 |
| 2000's | 1 (14.29) | 29.6817 |
| 2010's | 1 (14.29) | 24.3611 |
| 2020's | 2 (28.57) | 2.80 |
| Authors | Studies |
|---|---|
| Hernández-Mitre, MP | 1 |
| Tong, SYC | 1 |
| Denholm, JT | 1 |
| Dore, GJ | 1 |
| Bowen, AC | 1 |
| Lewin, SR | 1 |
| Venkatesh, B | 1 |
| Hills, TE | 1 |
| McQuilten, Z | 1 |
| Paterson, DL | 1 |
| Morpeth, SC | 1 |
| Roberts, JA | 1 |
| Chen, R | 1 |
| Hornemann, T | 1 |
| Štefanić, S | 1 |
| Schraner, EM | 1 |
| Zuellig, R | 1 |
| Reding, T | 1 |
| Malagola, E | 1 |
| Henstridge, DC | 1 |
| Hills, AP | 1 |
| Graf, R | 1 |
| Sonda, S | 1 |
| da Costa, MZ | 1 |
| Pires, JG | 1 |
| Nasser, PD | 1 |
| Ferreira, Cda S | 1 |
| Teixeira, AC | 1 |
| Paranaguá-Vezozzo, DC | 1 |
| Guarita, DR | 1 |
| Carrilho, FJ | 1 |
| Ono, SK | 1 |
| Bruin, T | 1 |
| Tuzgöl, S | 1 |
| van Diermen, DE | 1 |
| Hoogerbrugge-van der Linden, N | 1 |
| Brunzell, JD | 1 |
| Hayden, MR | 1 |
| Kastelein, JJ | 1 |
| Zhu, Y | 1 |
| Bujo, H | 1 |
| Takahashi, K | 1 |
| Taira, K | 1 |
| Kobayashi, J | 1 |
| Koshikawa, H | 1 |
| Sasaki, Y | 1 |
| Kanoh, T | 1 |
| Saito, Y | 1 |
| Porembskiĭ, OB | 1 |
| Slobozhankin, AD | 1 |
| Orlova, TO | 1 |
| Idelson, LI | 1 |
| Didkowsky, NA | 1 |
| Casey, R | 1 |
| Lorkin, PA | 1 |
| Lehmann, H | 1 |
1 review available for serine and Acute Edematous Pancreatitis
| Article | Year |
|---|---|
Nafamostat Mesylate for Treatment of COVID-19 in Hospitalised Patients: A Structured, Narrative Review.
Topics: Acute Disease; Antiviral Agents; Benzamidines; COVID-19 Drug Treatment; Fibrinolytic Agents; Guanidi | 2022 |
6 other studies available for serine and Acute Edematous Pancreatitis
| Article | Year |
|---|---|
Serine administration as a novel prophylactic approach to reduce the severity of acute pancreatitis during diabetes in mice.
Topics: Acinar Cells; Animals; Apoptosis; Ceruletide; Diabetes Mellitus, Experimental; Disease Models, Anima | 2020 |
Frequency of Tabagism and N34S and P55S Mutations of Serine Peptidase Inhibitor, Kazal Type 1 (SPINK1) and R254W Mutation of Chymotrypsin C (CTRC) in Patients With Chronic Pancreatitis and Controls.
Topics: Chronic Disease; Chymotrypsin; Genetic Predisposition to Disease; Humans; Mutation; Pancreatitis; Se | 2016 |
Recurrent pancreatitis and chylomicronemia in an extended Dutch kindred is caused by a Gly154-->Ser substitution in lipoprotein lipase.
Topics: Adult; Base Sequence; Cell Line; Chylomicrons; DNA; Glycine; Humans; Lipoprotein Lipase; Male; Molec | 1993 |
Severe hypertriglyceridemia with plasma inhibitory factor(s) on lipoprotein lipase activity in a patient with a common Ser(447)-Ter LPL mutation.
Topics: Acute Disease; Adult; Enzyme Inhibitors; Heparin; Humans; Hypertriglyceridemia; Lipoprotein Lipase; | 2001 |
[Conservative treatment of chronic, relapsing pancreatitis].
Topics: Anesthesia, Conduction; Ascorbic Acid; Blood Protein Disorders; Chronic Disease; Humans; Hydrocortis | 1968 |
Structure and function of haemoglobin Tacoma (beta 30 Arg yields Ser) found in a second family.
Topics: Amino Acid Sequence; Arginine; Blood Protein Electrophoresis; Chemical Phenomena; Chemistry; Chromat | 1974 |